Total:10
-
2022-03-01 18:07
“Noora” vaccine receives emergency use license
TEHRAN – Noora coronavirus vaccine, developed and produced by Baqiyatallah University of Medical Sciences, affiliated with the Islamic Revolution Guards Corps (IRGC), has received an emergency use license.
-
2021-12-31 17:04
Negotiations underway to export Razi Cov Pars vaccine
TEHRAN – A number of countries have requested to purchase the Iranian-made Cov Pars vaccine for COVID-19, and negotiations are underway to take the necessary measures for export, vice president for research and technology of Razi Vaccine and Serum Research Institute, said.
-
2021-11-17 17:50
By Faranak Bakhtiari
Over 100m doses of COVID-19 vaccine injected
TEHRAN – The number of COVID-19 vaccines injected in the country has exceeded 100 million doses, despite all barriers and difficulties caused by sanctions.
-
2021-11-14 19:00
Cov Pars causes 9-12 months immunity to COVID-19
TEHRAN – Studies show that Cov Pars vaccine, developed by the Razi Vaccine and Serum Research Institute of Iran, makes immunity for 9-12 months against the coronavirus, Reza Bani-Hashemi, the director for research and development at the institute, said on Sunday.
-
2021-11-12 17:12
COVIRAN vaccine to begin clinical trial on children aged 12-18
TEHRAN – COVIRAN BAREKAT vaccine received a license to start a clinical trial on children aged 12 to 18 by the next week, Minoo Mohraz, a member of the National Scientific Committee of COVID-19, has said.
-
2021-11-07 17:39
Monthly COVID-19 vaccine output reaches 10m doses
TEHRAN – The domestic manufacturers of coronavirus vaccine have managed to increase their monthly production to 10 million doses, Seyed Heydar Mohammadi, an official with the Food and Drug Administration, has said.
-
2021-10-08 17:22
Spikogen vaccine licensed for emergency use
TEHRAN – The Food and Drug Administration has issued an emergency permit for the Iranian-Australian Spikogen vaccine, IRNA reported on Thursday.
-
2021-09-13 17:16
Fakhra vaccine enters third phase of human test
TEHRAN – The third phase of the Fakhra vaccine’s human trial started on Monday by being administrated to 40,000 volunteers, IRIB reported.
-
2021-09-08 18:16
Pastu Covac vaccine approved for children under 18
TEHRAN – Pastu Covac, developed jointly by the Pasteur Institute of Iran and Cuba's Finlay Vaccine Institute, is the only homegrown vaccine that includes use in children aged under 18.
-
2021-09-05 18:17
Cov Pars begins third phase of clinical studies
TEHRAN – “Razi Cov Pars” vaccine entered on Sunday the third phase of the human trial, being administrated to 40,000 people, IRIB reported.